AlzChem Group Dividends and Buybacks
Dividend criteria checks 2/6
AlzChem Group is a dividend paying company with a current yield of 1.5% that is well covered by earnings.
Key information
1.5%
Dividend yield
0.1%
Buyback Yield
| Total Shareholder Yield | 1.6% |
| Future Dividend Yield | 2.3% |
| Dividend Growth | -14.3% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 32% |
Recent dividend and buyback updates
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80
May 03
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80
Mar 28AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80
Mar 03AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 26AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20
Mar 29Recent updates
A Look At The Fair Value Of AlzChem Group AG (ETR:ACT)
May 19What AlzChem Group AG's (ETR:ACT) 29% Share Price Gain Is Not Telling You
May 05AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80
May 03Is It Too Late To Consider Buying AlzChem Group AG (ETR:ACT)?
May 01AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80
Mar 28With EPS Growth And More, AlzChem Group (ETR:ACT) Makes An Interesting Case
Mar 18AlzChem Group AG (ETR:ACT) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 05AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80
Mar 03Market Still Lacking Some Conviction On AlzChem Group AG (ETR:ACT)
Feb 19
Expansion Of Nitroguanidine Production To Meet Defense Industry Demand Is Expected To Strengthen Market Position
Strategic expansion in production capacities and collaboration with the U.S. Department of Defense could bolster long-term revenue and market diversification.AlzChem Group's (ETR:ACT) Earnings May Just Be The Starting Point
Nov 14AlzChem Group AG's (ETR:ACT) Shares Leap 26% Yet They're Still Not Telling The Full Story
Oct 27When Should You Buy AlzChem Group AG (ETR:ACT)?
Oct 18AlzChem Group (ETR:ACT) Has A Pretty Healthy Balance Sheet
Sep 07A Look At The Intrinsic Value Of AlzChem Group AG (ETR:ACT)
Jun 04AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising
May 08Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being
May 01AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 26Is AlzChem Group (ETR:ACT) A Risky Investment?
Apr 11AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20
Mar 29The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More
Mar 07Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching
Nov 01Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?
Oct 12AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
May 06AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment
May 05AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05
Apr 05AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
Mar 04AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year
Apr 24AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00
Mar 29AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00
Feb 27AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 23Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?
Jun 10Stability and Growth of Payments
Fetching dividends data
Stable Dividend: ACT has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: ACT's dividend payments have increased, but the company has only paid a dividend for 7 years.
Dividend Yield vs Market
| AlzChem Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ACT) | 1.5% |
| Market Bottom 25% (DE) | 1.5% |
| Market Top 25% (DE) | 4.3% |
| Industry Average (Chemicals) | 4.0% |
| Analyst forecast (ACT) (up to 3 years) | 2.3% |
Notable Dividend: ACT's dividend (1.5%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.53%).
High Dividend: ACT's dividend (1.5%) is low compared to the top 25% of dividend payers in the German market (4.32%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (32.4%), ACT's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (23.4%), ACT's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/25 02:03 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AlzChem Group AG is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| Gerhard Orgonas | Berenberg |